EP2552452A1 - EGFR INHIBITOR AND ANTIVIRAL AGENT FOR SIMULTANEOUS, SEPARATE OR SEQUENTIAL USE IN THE TREATMENT AND/OR PREVENTION AND/OR PALLIATION OF CANCER